LeMaitre Vascular, Inc. (LMAT)
-NasdaqGM 6.20 
0.03(0.49%) 1:58PM EDT - Nasdaq Real Time Price
| Prev Close: | 6.17 |
|---|
| Open: | 6.15 |
|---|
| Bid: | 6.18 x 100 |
|---|
| Ask: | 6.25 x 4200 |
|---|
| 1y Target Est: | 8.50 |
|---|
| Beta: | -0.19 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 6.15 - 6.24 |
|---|
| 52wk Range: | 4.81 - 6.50 |
|---|
| Volume: | 7,649 |
|---|
| Avg Vol (3m): | 18,406 |
|---|
| Market Cap: | 94.55M |
|---|
| P/E (ttm): | 32.71 |
|---|
| EPS (ttm): | 0.19 |
|---|
| Div & Yield: | 0.12 (1.90%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- LeMaitre Vascular to Present at the Sidoti & Company, LLC, Semi-Annual Microcap Conference on Friday, June 7, 2013GlobeNewswire(Thu, May 23)
- LeMaitre Vascular Ranked in Boston Globe Top 100 Businesses in MassachusettsGlobeNewswire(Mon, May 20)
- LeMaitre Vascular (LMAT) Goes Ex-Dividend Soonat Forbes(Thu, May 16)
- LeMaitre Vascular To Present At The Second Annual Marcum LLP MicroCap ConferencePR Newswire(Wed, May 15)
- LEMAITRE VASCULAR INC FinancialsEDGAR Online Financials(Tue, May 14)
- LeMaitre Vascular to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on May 16thGlobeNewswire(Thu, May 9)
- LeMaitre Vascular to Present at the Three Part Advisors East Coast IDEAS Conference on May 15thGlobeNewswire(Wed, May 8)
- LEMAITRE VASCULAR INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 8)
- SNN Sales Beat but Earnings Miss on Weak ResultsZacks(Mon, May 6)
- Symmetry 1Q Earnings DisappointZacks(Fri, May 3)
- Hanger 1Q Earnings BeatZacks(Thu, May 2)
- LeMaitre Vascular's CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, Apr 30)
- LeMaitre Vascular, Inc. Earnings Call scheduled for 5:00 pm ET todayCCBN(Tue, Apr 30)
- LeMaitre Q1 2013 Record Sales $15.4mm (+11% Organic), Op. Profit $1.1mmGlobeNewswire(Tue, Apr 30)
- LEMAITRE VASCULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhEDGAR Online(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 25.90 |
|---|
| P/S (ttm): | 1.62 |
|---|
| Ex-Dividend Date: | 20-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.20 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.04 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | 1.54 |
|---|
Business Summary
LeMaitre Vascular, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of medical devices and implants for the treatment of peripheral vascular disease worldwide.
View More